Eunice Kennedy Shriver National Institute of Child Health & Human Development; Amended Notice of Meeting
| Published date | 20 November 2020 |
| Citation | 85 FR 74360 |
| Record Number | 2020-25630 |
| Section | Notices |
| Court | National Institutes Of Health |
74360
Federal Register / Vol. 85, No. 225 / Friday, November 20, 2020 / Notices
the IHS and to the HHS Office of
Inspector General all information
related to violations of Federal criminal
law involving fraud, bribery, or gratuity
violations potentially affecting the
Federal award. 45 CFR 75.113.
Disclosures must be sent in writing to:
U.S. Department of Health and
Human Services, Indian Health Service,
Division of Grants Management, ATTN:
Paul Gettys, Acting Director, 5600
Fishers Lane, Mail Stop: 09E70,
Rockville, MD 20857, (Include
‘‘Mandatory Grant Disclosures’’ in
subject line), Office: (301) 443–5204,
Fax: (301) 594–0899, Email:
Paul.Gettys@ihs.gov.
AND
U.S. Department of Health and
Human Services, Office of Inspector
General, ATTN: Mandatory Grant
Disclosures, Intake Coordinator, 330
Independence Avenue SW, Cohen
Building, Room 5527, Washington, DC
20201, URL: https://oig.hhs.gov/fraud/
report-fraud/ (Include ‘‘Mandatory
Grant Disclosures’’ in subject line), Fax:
(202) 205–0604 (Include ‘‘Mandatory
Grant Disclosures’’ in subject line) or
Email: MandatoryGranteeDisclosures@
oig.hhs.gov.
Failure to make required disclosures
can result in any of the remedies
described in 45 CFR 75.371 Remedies
for noncompliance, including
suspension or debarment (see 2 CFR
parts 180 & 376).
VII. Agency Contacts
1. Questions on the programmatic
issues may be directed to: Tamara
James, Ph.D., Division of Behavioral
Health, 5600 Fishers Lane, Mail Stop:
08N34A, Rockville, MD 20857, Phone:
(301) 443–2038, Fax: (301) 594–6213,
tamara.james@ihs.gov.
2. Questions on grants management
and fiscal matters may be directed to:
Donald Gooding, Grants Management
Specialist, 5600 Fishers Lane, Mail
Stop: 09E70, Rockville, MD 20857,
Phone: (301) 443–2298, Fax: (301) 594–
0899, Email: Gooding.Donald@ihs.gov.
3. Questions on systems matters may
be directed to: Paul Gettys, Acting
Director, DGM, 5600 Fishers Lane, Mail
Stop: 09E70, Rockville, MD 20857,
Phone: (301) 443–2114; or the DGM
main line (301) 443–5204, Fax: (301)
594–0899, Email: Paul.Gettys@ihs.gov.
VIII. Other Information
The Public Health Service strongly
encourages all grant, cooperative
agreement and contract recipients to
provide a smoke-free workplace and
promote the non-use of all tobacco
products. In addition, Public Law 103–
227, the Pro-Children Act of 1994,
prohibits smoking in certain facilities
(or in some cases, any portion of the
facility) in which regular or routine
education, library, day care, health care,
or early childhood development
services are provided to children. This
is consistent with the HHS mission to
protect and advance the physical and
mental health of the American people.
Michael D. Weahkee,
RADM, Assistant Surgeon General, U.S.
Public Health Service, Director, Indian Health
Service.
[FR Doc. 2020–25642 Filed 11–19–20; 8:45 am]
BILLING CODE 4165–16–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
Eunice Kennedy Shriver National
Institute of Child Health & Human
Development; Amended Notice of
Meeting
Notice is hereby given of a change in
the meeting of the National Institute of
Child Health and Human Development
Special Emphasis Panel, August 7, 2020,
8:00 a.m. to 5:00 p.m., National Institute
of Child Health and Human
Development, 6710B Rockledge Drive,
Bethesda, MD 20892 which was
published in the Federal Register on
July 10, 2020, 85 FR 41606.
The meeting date changed from
August 7, 2020, 8:00 a.m.–5:00 p.m. to
December 14, 2020, 10:00 a.m. to 6:00
p.m. The meeting is closed to the
public.
Dated: November 16, 2020.
Ronald J. Livingston, Jr.,
Program Analyst, Office of Federal Advisory
Committee Policy.
[FR Doc. 2020–25630 Filed 11–19–20; 8:45 am]
BILLING CODE 4140–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
National Institute of Mental Health;
Notice of Meeting
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended, notice is hereby given of a
meeting of the National Advisory
Mental Health Council.
The meeting will be open to the
public as indicated below, with
attendance limited to space available.
Individuals who plan to attend and
need special assistance, such as sign
language interpretation or other
reasonable accommodations, should
notify the Contact Person listed below
in advance of the meeting.
The meeting will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: National Advisory
Mental Health Council.
Date: February 2–3, 2021.
Open: February 02, 2021, 12:00 p.m. to
3:30 p.m.
Agenda: Presentation of the NIMH
Director’s Report and discussion of NIMH
program.
Place: National Institutes of Health,
Neuroscience Center, 6001 Executive
Boulevard, Rockville, MD 20852, (Virtual
Meeting).
Closed: February 02, 2021, 3:30 p.m. to
4:00 p.m.
Agenda: To review and evaluate the NIMH
Division of Intramural Research Programs.
Place: National Institutes of Health,
Neuroscience Center, 6001 Executive
Boulevard, Rockville, MD 20852 (Virtual
Meeting).
Closed: February 03, 2021, 12:00 p.m. to
1:00 p.m.
Agenda: To review and evaluate the NIMH
Division of Intramural Research Programs.
Place: National Institutes of Health,
Neuroscience Center, 6001 Executive
Boulevard, Rockville, MD 20852 (Virtual
Meeting).
Closed: February 03, 2021, 1:00 p.m. to
4:00 p.m.
Agenda: To review and evaluate grant
applications and/or proposals.
Place: National Institutes of Health,
Neuroscience Center, 6001 Executive
Boulevard, Rockville, MD 20852 (Virtual
Meeting).
Contact Person: Rebecca Wagenaar-Miller,
Ph.D., Acting Deputy Director, Division of
Extramural Activities, National Institute of
Mental Health, National Institutes of Health,
NSC Bldg., 6001 Executive Blvd., Room 6160,
Rockville, MD 20852, 301–435–0322,
rwagenaa@mail.nih.gov.
Any interested person may file written
comments with the committee by forwarding
the statement to the Contact Person listed on
this notice. The statement should include the
name, address, telephone number and when
applicable, the business or professional
affiliation of the interested person.
Information is also available on the
Institute’s/Center’s home page:
www.nimh.nih.gov/about/advisory-boards-
and-groups/namhc/index.shtml., where an
agenda and any additional information for
the meeting will be posted when available.
VerDate Sep<11>2014 17:08 Nov 19, 2020 Jkt 253001 PO 00000 Frm 00051 Fmt 4703 Sfmt 4703 E:\FR\FM\20NON1.SGM 20NON1
khammond on DSKJM1Z7X2PROD with NOTICES
